FENC · Fennec Pharmaceuticals Inc. · Executive Compensation
$10.33
-0.32 (-3.00%)
At close · Oct 1
Return incl. dividend (before tax)
Market Cap
$371.89M
Shares
35.07M
Volume · Oct 1
130.15K
Avg daily vol (3M)
195.47K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Rostislav Raykov | CEO | $2,124,216 |
| Robert Andrade | CFO | $1,158,858 |
| Shubh Goel | CCO | $529,422 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Rostislav Raykov | CEO | $1,476,536 |
| Shubh Goel | CCO | $1,029,538 |
| Robert Andrade | CFO | $863,766 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Rostislav Raykov | CEO | $1,072,261 |
| Robert Andrade | CFO | $669,099 |
| Shubh Goel | CCO | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Rostislav Raykov | Board of Directors | Retired | 2026-04-28 |
| Christiana Cioffi | Chief Strategy Officer ("CSO") | Appointed | 2024-10-30 |
| Terry Evans | Chief Commercial Officer ("CCO") | Appointed | 2024-10-30 |
| Pierre S. Sayad | Chief Medical Officer ("CMO") | Appointed | 2024-10-30 |
| Jeff Hackman | member of the Board of Directors | Appointed | 2024-08-07 |
| Jeff Hackman | Chief Executive Officer | Appointed | 2024-08-07 |
| Jeffrey S. Hackman | member of the Board | Appointed | 2024-08-07 |
| Jeffrey S. Hackman | Chief Executive Officer | Appointed | 2024-08-07 |
| Adrian Haigh | Chief Operating Officer | Resigned | 2024-07-02 |
| Adrian Haigh | Chief Operating Officer | Appointed | 2023-08-04 |